The FDA will temporarily allow a replacement drug for Doxil, a drug for ovarian and other cancers, to be imported. The drug has not been available to new patients for months. The FDA also approved a supplier for a preservative-free version of methotrexate, which is used to treat children with acute lymphoblastic leukemia and bone cancer.
Related Articles on Supply Chain:
Cardinal Health to Start Offering its Complete Portfolio of Surgical Gloves in Sustainable, Half-Fold Packaging
Teleflex Signs Agreement With HealthTrust for Arrow Intra-Aortic Balloon Pumps and Catheters
SourceMedical Launches Vision OnDemand Clinical and Business Management System for ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.